Fundraising Fox

Amplitude Vascular Systems

Boston, US · Founded 2019 · Delaware corporation · 1 known investors

BiotechHealthtech

Founders & leadership

AC
Andrew CaseyExecutive
SG
Sean GilliganExecutive
MT
Mark TolandExecutiveManaging Director at BioStar Capital
RC
Robert ChisenaNamed on SEC filing
DL
David LongNamed on SEC filing

Board

LC
Louis CannoninBoard directorFounder, Senior Managing Director at BioStar Capital
HG
Hitinder GurmBoard director
JR
Jason RichardsonBoard director
WH
William H. KuchemanBoard director

Investors · 1

BioStar CapitalCharlevoix · $250K – $3Mvia William H. (Hank) Kucheman · board

Reported raises · per SEC filings

Form D private placements

$29.3M disclosed across 3 rounds · 2020–2024

▶$23.6MraisedOct 2024 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hitinder GurmDirector
  • Robert ChisenaExecutive Officer
  • Jason RichardsonDirector
  • Louis CannonDirector
  • Andrew CaseyExecutive Officer
  • Sean GilliganExecutive Officer
  • William H. KuchemanDirector
  • Mark TolandExecutive Officer, Director
Offering amount
$36M
Amount sold
$23.6M
Minimum investment
$10K
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedOct 2022 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark TolandExecutive Officer, Director
  • Louis CannonDirector
  • David LongDirector
  • Hitinder GurmDirector
  • Hank KuchemanDirector
  • Robert ChisenaExecutive Officer
Offering amount
$22.4M
Amount sold
$4.4M
Minimum investment
$10K
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJul 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LongDirector
  • Mark TolandExecutive Officer, Director
  • Hitinder GurmExecutive Officer, Director
  • Robert ChisenaExecutive Officer, Director
  • Louis CannonDirector
Offering amount
$1.5M
Amount sold
$1.2M
Minimum investment
$10K
Proceeds to insiders
$470K
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystembusinesswire.com · May 2026AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch | Healthcare IT Todayhealthcareittoday.com · Mar 2025AVS completes US$36 million Series B financing ahead of IVL US commercial launch - Vascular Newsvascularnews.com · Jan 2025AVS Raises $36M in Series B Fundingfinsmes.com · Jan 2025Amplitude Vascular's New Funding Round Shows Why the IVL Market Is Red Hotmddionline.com · Jan 2025AVS Raises Financing to Support Pulse IVL System Launch in the United States - Endovascular Todayevtoday.com · Jan 2025

Frequently asked questions

Who are Amplitude Vascular Systems's investors?
Amplitude Vascular Systems's investors include BioStar Capital.
How much funding has Amplitude Vascular Systems raised?
Amplitude Vascular Systems has disclosed $29.3M raised across 3 rounds.
Where is Amplitude Vascular Systems headquartered?
Amplitude Vascular Systems is headquartered in Boston, US.